Figure 1. SBP trajectory (mean ±1 SE) over time in the entire VICTORIA population (A), and by subgroups of age below (B) or above (C) 75 years; SBP above (D) or below (E) 110 mm Hg; and those not receiving (F) or receiving (G) ARNI at baseline.

ARNI indicates angiotensin receptor neprilysin inhibitors; SBP: systolic blood pressure; and VICTORIA: Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction.